Posted in NYTBusiness Day, ROBERT CYRAN

Pfizer Remains Whole, but the Option to Split Could Return (via Pocket)

Pfizer has finally admitted that there is no rabbit in its breakup hat. After spending $600 million over several years studying and preparing for a possible split, the drug company said on Monday that it had decided to remain whole. Pfizer’s chief executive, Ian C.

Added @ September 27, 2016 at 07:36AM from http://ift.tt/2dwOATy